Literature DB >> 17551483

Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors.

Gerasimos E Krassas1, Petros Perros.   

Abstract

Primary, secondary and tertiary prevention are defined according to the timing of the preventive intervention in the natural history of a disease. Secondary prevention in Graves' ophthalmopathy (GO) is challenging in the absence of reliable specific serum markers for subclinical GO that would allow an early diagnosis. Some risk factors for occurrence or progression of GO have been identified. Cigarette smoking, thyroid dysfunction and radioactive iodine (RAI) are known preventable risk factors. The list is probably much longer, and future research should be aimed at identifying more. Smoking cessation, restoration of euthyroidism by antithyroid drugs or L-thyroxine, glucocorticoid coverage after RAI or deferring RAI until the eye disease is inactive, may prevent progression of GO. Passive smoking seems to exacerbate autoimmune thyroid disease (AITD) in general, and may have a deleterious effect on childhood GO in particular, therefore avoidance of passive smoking is likely to be beneficial.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551483

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  4 in total

1.  Clinical features of pediatric Graves' orbitopathy.

Authors:  J Eha; S Pitz; J Pohlenz
Journal:  Int Ophthalmol       Date:  2010-02-27       Impact factor: 2.031

Review 2.  2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.

Authors:  Thanh D Hoang; Derek J Stocker; Eva L Chou; Henry B Burch
Journal:  Endocrinol Metab Clin North Am       Date:  2022-05-11       Impact factor: 4.748

3.  Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.

Authors:  Dalia Jarusaitiene; Rasa Verkauskiene; Vytautas Jasinskas; Jurate Jankauskiene
Journal:  Int J Endocrinol       Date:  2016-06-16       Impact factor: 3.257

Review 4.  Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review.

Authors:  Nickisa M Hodgson; Fatemeh Rajaii
Journal:  Ophthalmol Ther       Date:  2019-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.